Modified directly observed therapy to improve HIV treatment outcomes: Little impact with potent, once-daily therapy in unselected antiretroviral-naïve patients

被引:7
作者
David R. Bangsberg
机构
[1] Mbarara University of Science and Technology,Massachusetts General Hospital Center for Global Health, Ragon Institute of MGH, MIT, and Harvard, and Harvard Medical School
[2] Harvard Initiative for Global Health,undefined
关键词
Tenofovir; Stavudine; Virologic Failure; Lopinavir; Emtricitabine;
D O I
10.1007/s11904-009-0031-y
中图分类号
学科分类号
摘要
引用
收藏
页码:173 / 174
页数:1
相关论文
共 35 条
[1]  
Bangsberg D.R.(2000)Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population AIDS 14 357-366
[2]  
Hecht F.M.(2000)Adherence to protease inhibitor therapy and outcomes in patients with HIV infection Ann Intern Med 133 21-30
[3]  
Charlebois E.D.(2002)Response to lamivudine-zidovudine plus abacavir twice daily in antiretroviral-naive, incarcerated patients with HIV infection taking directly observed treatment Clin Infect Dis 34 511-518
[4]  
Paterson D.L.(2007)Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial Clin Infect Dis 45 770-778
[5]  
Swindells S.(2007)A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users AIDS 21 1473-1477
[6]  
Mohr J.(2003)Adherence to directly observed antiretroviral therapy among human immunodeficiency virus-infected prison inmates Clin Infect Dis 36 1572-1576
[7]  
Kirkland L.R.(2004)Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study Clin Infect Dis 38Suppl5 S409-S413
[8]  
Fischl M.A.(2005)Couple-focused support to improve HIV medication adherence: a randomized controlled trial AIDS 19 807-814
[9]  
Tashima K.T.(2006)Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004 J Acquir Immune Defic Syndr 41 285-297
[10]  
Altice F.L.(2007)A lopinavir/ritonavir-based once-daily regimen results in better compliance and is non-inferior to a twice-daily regimen through 96 weeks AIDS Res Hum Retroviruses 23 1505-1514